Inositol phosphoglycans and preeclampsia: From bench to bedside

Journal of Reproductive Immunology

Volumn 89, Issue 2, 2011, Pages 173-177

  Scioscia, Marco ^a   Williams, Philip J ^b   Gumaa, Khalid ^c   Fratelli, Nicola ^a   Zorzi, Carlotta ^a   Rademacher, Thomas W ^b  

^a Sacro Cuore Don Calabria ^*  (Italy)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

Abnormal stimuli; First trimester; Inositol phosphoglycan; Insulin resistance; Preeclampsia

Indexed keywords

GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; GLYCOGEN SYNTHASE PHOSPHATASE; INOSITOL; INSULIN; LIPOPHOSPHOGLYCAN; PYRUVATE DEHYDROGENASE PHOSPHATASE;

CASE CONTROL STUDY; CLINICAL ASSESSMENT; EXCRETION; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; GLUCOSE METABOLISM; GLYCOGEN METABOLISM; GLYCOGENOLYSIS; HUMAN; INSULIN RESISTANCE; KNOWLEDGE; METABOLIC SYNDROME X; MOLECULE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; REVIEW; SECOND TRIMESTER PREGNANCY; URINARY EXCRETION;

FEMALE; FETUS; GLUCOSE; GLYCOGEN; HUMANS; INFLAMMATION; INOSITOL PHOSPHATES; METABOLIC SYNDROME X; PLACENTA; POLYSACCHARIDES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, THIRD;

EID: 79956089679     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2011.03.001     Document Type: Review

References (41)

1. Arkwright P.D., Rademacher T.W., Dwek R.A., Redman C.W. Pre-eclampsia is associated with an increase in trophoblast glycogen content and glycogen synthase activity, similar to that found in hydatidiform moles. J. Clin. Invest. 1993, 91:2744-2753.
2. Burton G.J., Jauniaux E., Charnock-Jones D.S. Human early placental development: potential roles of the endometrial glands. Placenta 2007, 28(Suppl. A):S64-S69.
3. Burton G.J., Watson A.L., Hempstock J., Skepper J.N., Jauniaux E. Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy. J. Clin. Endocrinol. Metab. 2002, 87:2954-2959.
4. Caro H.N., Sheikh N.A., Taverne J., Playfair J.H., Rademacher T.W. Structural similarities among malaria toxins insulin second messengers, and bacterial endotoxin. Infect. Immun. 1996, 64:3438-3441.
5. Elased K.M., Gumaa K.A., de Souza J.B., Playfair J.H., Rademacher T.W. Improvement of glucose homeostasis in obese diabetic db/db mice given Plasmodium yoelii glycosylphosphatidylinositols. Metabolism 2004, 53:1048-1053.
6. Elased K.M., Gumaa K.A., de Souza J.B., Rahmoune H., Playfair J.H., Rademacher T.W. Reversal of type 2 diabetes in mice by products of malaria parasites. II. Role of inositol phosphoglycans (IPGs). Mol. Genet. Metab. 2001, 73:248-258.
7. Emery S.P., Levine R.J., Qian C., Ewell M.G., England L.J., Yu K.F., Catalano P.M. Twenty-four-hour urine insulin as a measure of hyperinsulinaemia/insulin resistance before onset of pre-eclampsia and gestational hypertension. BJOG 2005, 112:1479-1485.
8. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 1999, 340:448-454.
9. Hay W.W. Recent observations on the regulation of fetal metabolism by glucose. J. Physiol. 2006, 572:17-24.
10. Hempstock J., Cindrova-Davies T., Jauniaux E., Burton G.J. Endometrial glands as a source of nutrients, growth factors and cytokines during the first trimester of human pregnancy: a morphological and immunohistochemical study. Reprod. Biol. Endocrinol. 2004, 2:58-60.
11. Jauniaux E., Hempstock J., Teng C., Battaglia F.C., Burton G.J. Polyol concentrations in the fluid compartments of the human conceptus during the first trimester of pregnancy: maintenance of redox potential in a low oxygen environment. J. Clin. Endocrinol. Metab. 2005, 90:1171-1175.
12. Jones C.J., Aplin J.D., Burton G.J. First trimester histiotrophe shows altered sialylation compared with secretory phase glycoconjugates in human endometrium. Placenta 2010, 31:576-580.
13. Kunjara S., Greenbaum A.L., Wang D.Y., Caro H.N., McLean P., Redman C.W., Rademacher T.W. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels. Mol. Genet. Metab. 2000, 69:144-158.
14. Kunjara S., McLean P., Greenbaum A.L., Rademacher T.W. Insight into the role of inositol phosphoglycans in insulin response and the regulation of glucose and lipid metabolism illustrated by the response of adipocytes from two strains of rats. Mol. Genet. Metab. 2008, 94:263-266.
15. Larner J. d-Chiro-inositol-its functional role in insulin action and its deficit in insulin resistance. Int. J. Exp. Diab. Res. 2002, 3:47-60.
16. Lazar D.F., Knez J.J., Medof M.E., Cuatrecasas P., Saltiel A.R. Stimulation of glycogen synthesis by insulin in human erythroleukemia cells requires the synthesis of glycosyl-phosphatidylinositol. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:9665-9669.
17. Matzinger P. Friendly and dangerous signals: is the tissue in control?. Nat. Immunol. 2007, 8:11-13.
18. Misek D.E., Saltiel A.R. An inositol phosphate glycan derived from a Trypanosoma brucei glycosyl phosphatidylinositol promotes protein dephosphorylation in rat epididymal adipocytes. Endocrinology 1994, 135:1869-1876.
19. NHBPEP Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am. J. Obstet. Gynecol. 2000, 183:S1-S22.
20. Paine M.A., Rodeck C.H., Williams P.J., Rademacher T.W. Possible involvement of inositol phosphoglycan-P in human parturition. J. Reprod. Immunol. 2003, 59:267-275.
21. Paine M.A., Scioscia M., Gumaa K.A., Rodeck C.H., Rademacher T.W. P-type inositol phosphoglycans in serum and amniotic fluid in active pre-eclampsia. J. Reprod. Immunol. 2006, 69:165-179.
22. Paine M.A., Scioscia M., Williams P.J., Gumaa K., Rodeck C.H., Rademacher T.W. Urinary inositol phosphoglycan P-type as a marker for prediction of preeclampsia and novel implications for the pathophysiology of this disorder. Hypertens. Pregnancy 2010, 29:375-384.
23. Rademacher T.W., Caro H., Kunjara S., Wang D.Y., Greenbaum A.L., McLean P. Inositolphosphoglycan second messengers. Braz. J. Med. Biol. Res. 1994, 27:327-341.
24. Rademacher T.W., Gumaa K., Scioscia M. Preeclampsia, insulin signalling and immunological dysfunction: a fetal, maternal or placental disorder?. J. Reprod. Immunol. 2007, 76:78-84.
25. Reddy A., Suri S., Sargent I.L., Redman C.W., Muttukrishna S. Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia. PLoS One 2009, 4:e4453-e4460.
26. Redman C.W., Sargent I.L. Pre-eclampsia, the placenta and the maternal systemic inflammatory response-a review. Placenta 2003, 24(Suppl. A):S21-S27.
27. Redman C.W., Sargent I.L. Latest advances in understanding preeclampsia. Science 2005, 308:1592-1594.
28. Redman C.W., Sargent I.L. Immunology of pre-eclampsia. Am. J. Reprod. Immunol. 2010, 63:534-543.
29. Scioscia M., Gumaa K., Kunjara S., Paine M.A., Selvaggi L.E., Rodeck C.H., Rademacher T.W. Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2. J. Clin. Endocrinol. Metab. 2006, 91:709-717.
30. Scioscia M., Vimercati A., Selvaggi L.E., Rodeck C.H., Rademacher T.W. Inositol phosphoglycan putative insulin mediator in human amniotic fluid. J. Matern. Fetal Neonatal Med. 2006, 19:9-12.
31. Scioscia M., Gumaa K., Whitten M., Selvaggi L.E., Rodeck C.H., Rademacher T.W. Inositol phosphoglycan P-type in healthy and preeclamptic pregnancies. J. Reprod. Immunol. 2007, 76:85-90.
32. Scioscia M., Kunjara S., Gumaa K., McLean P., Rodeck C.H., Rademacher T.W. Urinary excretion of inositol phosphoglycan P-type in gestational diabetes mellitus. Diab. Med. 2007, 24:1300-1304.
33. Scioscia M., Greco P., Selvaggi L.E., Rademacher T.W. Is there a link between insulin resistance and inflammatory activation in preeclampsia?. Med. Hypotheses 2009, 73:813-817.
34. Scioscia M., Gumaa K., Rademacher T.W. The link between insulin resistance and preeclampsia: new perspectives. J. Reprod. Immunol. 2009, 82:100-105.
35. Scioscia M., Gumaa K., Selvaggi L.E., Rodeck C.H., Rademacher T.W. Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus. J. Perinat. Med. 2009, 37:469-471.
36. Seely E.W., Solomon C.G. Insulin resistance and its potential role in pregnancy-induced hypertension. J. Clin. Endocrinol. Metab. 2003, 88:2393-2398.
37. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J. Clin. Invest. 2006, 116:1793-1801.
38. Suzuki S., Kawasaki H., Satoh Y., Ohtomo M., Hirai M., Hirai A., Hirai S., Onoda M., Matsumoto M., Hinokio Y. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes. Diab. Care 1994, 17:1465-1468.
39. Varela-Nieto I., Leon Y., Caro H.N. Cell signalling by inositol phosphoglycans from different species. Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 1996, 115:223-241.
40. Villar-Palasi C., Farese R.V. Impaired skeletal muscle glycogen synthase activation by insulin in the Goto-Kakizaki (G/K) rat. Diabetologia 1994, 37:885-888.
41. Williams P.J., Gumaa K., Scioscia M., Redman C.W., Rademacher T.W. Inositol phosphoglycan P-type in preeclampsia: a novel marker?. Hypertension 2007, 49:84-89.